文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Skeletal muscle wasting occurs in adult rats under chronic treatment with paracetamol when glutathione-dependent detoxification is highly activated.

作者信息

Mast C, Joly C, Savary-Auzeloux I, Remond D, Dardevet D, Papet I

机构信息

Clermont Universite, Universite d'Auvergne, Unite de Nutrition Humaine, Clermont-Ferrand, France.

出版信息

J Physiol Pharmacol. 2014 Oct;65(5):623-31.


DOI:
PMID:25371521
Abstract

The use of glutathione (GSH) and sulfate for the detoxification of paracetamol (acetaminophen, APAP) could occur at the expense of the physiological uses of cysteine (Cys). Indeed GSH and sulfate both originate from Cys. Significant APAP-induced Cys loss could generate alterations in GSH and protein metabolisms leading to muscle wasting. The study aimed to investigate the effects of chronic treatment with APAP on whole-body and tissue homeostasis (mass, GSH, proteins, and nitrogen balance) in relation to sulfur losses through APAP-detoxification pathways. Adult male Wistar rats were fed 0% APAP, 0.5% APAP or 1% APAP diets for 17 days. APAP doses were respectively around and largely above the threshold of sulfation saturation for rats. During the last days, the rats were placed in metabolic cages in order to quantify N balance and urinary APAP metabolites. Gastrocnemius muscle mass, protein and GSH contents, N balance and plasma free cyst(e)ine were 8% (P=0.02), 7% (P=0.03), 26% (P=0.01), 37% (P=0.01), and 33% (P=0.003) lower in the 1% APAP group than in the 0% APAP group, respectively. There was no significant difference in these parameters between the 0.5% APAP group and the 0% APAP group. Muscle wasting occurred when the detoxification of APAP through the GSH-dependent pathway was highly activated. Muscle protein synthesis could have been reduced due to a shortage in Cys and/or an increase in protein degradation in response to intra-muscular oxidative stress. Hence, without dietary sulphur amino acid increase, peripheral bioavailability of Cys and muscle GSH are potential players in the control of muscle mass under chronic treatment with APAP, an analgesic medication of widespread use, especially in the elderly.

摘要

相似文献

[1]
Skeletal muscle wasting occurs in adult rats under chronic treatment with paracetamol when glutathione-dependent detoxification is highly activated.

J Physiol Pharmacol. 2014-10

[2]
Dietary supplementation with cysteine prevents adverse metabolic outcomes of repeated cures with paracetamol in old rats.

Br J Nutr. 2017-12

[3]
Impact of medication on protein and amino acid metabolism in the elderly: the sulfur amino acid and paracetamol case.

Nutr Res Rev. 2018-3-20

[4]
Repeated cures with paracetamol worsen sarcopenia in old rats with suboptimal food intake.

J Physiol Pharmacol. 2016-10

[5]
Acute acetaminophen toxicity in transgenic mice with elevated hepatic glutathione.

Vet Hum Toxicol. 2000-6

[6]
Metabolism and excretion of a glutathione conjugate of acetaminophen in the isolated perfused rat kidney.

J Pharmacol Exp Ther. 1986-5

[7]
Activation of the eIF2α-ATF4 Pathway by Chronic Paracetamol Treatment Is Prevented by Dietary Supplementation with Cysteine.

Int J Mol Sci. 2022-6-28

[8]
Nephrotoxicity of acetaminophen in male Wistar rats: role of hepatically derived metabolites.

J Pharmacol Exp Ther. 1996-11

[9]
Age-related changes in glutathione availability and skeletal muscle carbonyl content in healthy rats.

Exp Gerontol. 2004-2

[10]
Contribution of acetaminophen-cysteine to acetaminophen nephrotoxicity II. Possible involvement of the gamma-glutamyl cycle.

Toxicol Appl Pharmacol. 2005-1-15

引用本文的文献

[1]
Activation of the eIF2α-ATF4 Pathway by Chronic Paracetamol Treatment Is Prevented by Dietary Supplementation with Cysteine.

Int J Mol Sci. 2022-6-28

[2]
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity.

J Clin Transl Res. 2017-2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索